COMPOSITIONS AND METHODS FOR HIGH FIDELITY ASSEMBLY OF NUCLEIC ACIDS

    公开(公告)号:EP3954770A1

    公开(公告)日:2022-02-16

    申请号:EP21177267.8

    申请日:2012-08-23

    申请人: Gen9, Inc.

    摘要: Aspects of the invention relate to methods, compositions and algorithms for designing and producing a target nucleic acid. The method can include: (1) providing a plurality of blunt-end double-stranded nucleic acid fragments having a restriction enzyme recognition sequence at both ends thereof; (2) producing via enzymatic digestion a plurality of cohesive-end double-stranded nucleic acid fragments each having two different and non-complementary overhangs; (3) ligating the plurality of cohesive-end double-stranded nucleic acid fragments with a ligase; and (4) forming a linear arrangement of the plurality of cohesive-end double-stranded nucleic acid fragments, wherein the unique arrangement comprises the target nucleic acid. In certain embodiments, the plurality of blunt-end double-stranded nucleic acid fragments can be provided by: releasing a plurality of oligonucleotides synthesized on a solid support; and synthesizing complementary strands of the plurality of oligonucleotides using a polymerase based reaction.

    METHODS AND APPARATUSES FOR CHIP-BASED DNA ERROR REDUCTION

    公开(公告)号:EP3597771A1

    公开(公告)日:2020-01-22

    申请号:EP19174924.1

    申请日:2010-11-19

    申请人: Gen9, Inc.

    IPC分类号: C12Q1/68

    摘要: Methods and apparatus relate to reduction of sequence errors generated during synthesis of nucleic acids on a microarray chip. The error reduction can include synthesis of complementary strands (to template strands), using a short universal primer complementary to the template strands and polymerase. Heteroduplex can be formed by melting and re-annealing complementary strands and template strands. The heteroduplexes containing a mismatch can be recognized and cleaved by a mismatch endonuclease. The mismatch-containing cleaved heteroduplexes can be removed from the microarray chip using a global buffer exchange. The error free synthetic nucleic acids generated therefrom can be used for a variety of applications, including synthesis of biofuels and value-added pharmaceutical products.